Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or ...
Sydney, Australia Monday, March 16, 2026, 10:00 Hrs [IST] ...
Racura Oncology’s lead drug candidate RC220 has cleared an important regulatory hurdle after receiving governance approval from Monash Health to start a phase I clinical trial in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results